Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions

P. Langton, Graeme Hankey, J. Eikelboom

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)199
JournalMedical Journal of Australia
Volume182
Issue number4
Publication statusPublished - 2005

Cite this

@article{134c540d81684a71a377cc2f6a9180f3,
title = "Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions",
author = "P. Langton and Graeme Hankey and J. Eikelboom",
year = "2005",
language = "English",
volume = "182",
pages = "199",
journal = "Medical Journal Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Co. Ltd",
number = "4",

}

Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions. / Langton, P.; Hankey, Graeme; Eikelboom, J.

In: Medical Journal of Australia, Vol. 182, No. 4, 2005, p. 199.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions

AU - Langton, P.

AU - Hankey, Graeme

AU - Eikelboom, J.

PY - 2005

Y1 - 2005

M3 - Letter

VL - 182

SP - 199

JO - Medical Journal Australia

JF - Medical Journal Australia

SN - 0025-729X

IS - 4

ER -